Home > Boards > US Listed > Biotechs > Assembly Biosciences, Inc. (ASMB)

Noteworthy comment from ENTA’s FY2Q19 CC:

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 724
Posts 109,639
Boards Moderated 15
Alias Born 09/05/02
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2019 5:15:00 PM
Data for Assembly Biosciences’ First and Second Generation HBV Core Inhibitors in Development for the Treatment of Chronic ... GlobeNewswire Inc. - 11/11/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/7/2019 5:48:39 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 11/7/2019 5:43:47 PM
Assembly Biosciences Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire Inc. - 11/7/2019 5:30:00 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 11/7/2019 5:29:13 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/7/2019 4:45:50 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/7/2019 4:28:03 PM
Assembly Biosciences Reports Third Quarter 2019 Financial Results and Recent Highlights GlobeNewswire Inc. - 11/7/2019 4:05:00 PM
Assembly Biosciences Appoints Luisa Stamm, MD, PhD, as Chief Medical Officer GlobeNewswire Inc. - 11/7/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/28/2019 6:52:29 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/28/2019 6:47:34 PM
Assembly Biosciences Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire Inc. - 10/28/2019 5:15:05 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/28/2019 4:10:23 PM
Assembly Biosciences Appoints Thomas J. Russo as Chief Financial Officer GlobeNewswire Inc. - 10/28/2019 8:00:05 AM
Safety and Antiviral Activity of Assembly Biosciences’ First and Second Generation Core Inhibitor Candidates In the Treatme... GlobeNewswire Inc. - 10/16/2019 7:05:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 10/7/2019 4:20:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2019 6:33:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2019 6:11:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2019 6:06:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/9/2019 4:31:52 PM
Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire Inc. - 8/9/2019 4:30:00 PM
Assembly Biosciences Shares Rise as Gilead Vet Takes Helm Dow Jones News - 8/7/2019 12:44:00 PM
Assembly Biosciences Announces Appointment of John McHutchison, AO, MD, as President and Chief Executive Officer GlobeNewswire Inc. - 8/7/2019 8:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/5/2019 5:26:42 PM
DewDiligence Member Level  Tuesday, 05/07/19 05:59:02 PM
Re: None
Post # of 17 
Noteworthy comment from ENTA’s FY2Q19 CC:

#msg-148672065

Follow the Reply chain for related info.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist